David Lim Profile picture
Health reporter @POLITICO covering Covid-19 and the @US_FDA. @AAJA + @AHCJ. Prescription Pulse co-author. Tips: davidalim@protonmail.com. DM for Signal.
Dec 29, 2021 11 tweets 3 min read
Really interesting and telling interview by @chrislhayes with Anthony Fauci tonight on CDC's isolation guidance.

Gives insight into what CDC and top admin health officials were thinking.

Really blunt discussion of trade offs to keep society running during upcoming weeks.

🧵: Fauci: "So many people — now and likely in the next few weeks — who will be infected by this wave of infections that we're getting with Omicron ... that might have a negative impact on our ability to maintain the structure of society."
Dec 28, 2021 5 tweets 2 min read
CDC's estimate for the prevalence of Omicron last week dropped significantly from 73.2% w/ a 95% prediction interval of 34-94.9% down to 22.5% w/ a 95% prediction interval of 15.4-31.5%.

12/25 estimate is 58.6% with a 95% prediction interval of 41.5-74%. Statistics are hard and I know health media can do a better job communicating the uncertainty of these projections.

Would love to get some perspective from @cmyeaton @mlipsitch on how they think about this.
Mar 8, 2020 12 tweets 5 min read
Messaging on #COVID19 from present and former government officials is drastically changing today - but if you've been paying attention, it is consistent with what @DrNancyM_CDC said two weeks ago.

"Disruption to everyday life might be severe," she warned. (1/n) The World Health Organization has been slow to call #COVID19 a pandemic. But that is where we are today, experts tell me.

I've struggled immensely to determine what is appropriate language to use and which stories are responsible to write. I joined @POLITICO in January. (2/n)
Feb 29, 2020 6 tweets 6 min read
NEW: @US_FDA issues immediate guidance to allow high-complexity labs to create their own #COVID19 tests, which @POLITICO reported yesterday.

Allow labs to immediately use tests BEFORE the agency grants an emergency use authorization.

Document here: fda.gov/media/135659/d… @US_FDA @politico “We believe this action will support laboratories across the country working on this urgent public health situation," medical device chief regulator Jeff Shuren said.

Labs still must validate tests prior to use - and a disclaimer that FDA review is pending must be given.